Multiplex Assay Kit for Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay)
Ref: CC-LMP657Hu
SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15
Información del producto
Especificidad:
This assay has high sensitivity and excellent specificity for detection of Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.
Información adicional
Applications
FLIA Kit for Antigen Detection.
Detection Range
0.1-100ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.033 ng/mL
Specificity
Research Area
Tumor immunity
Organism species
Homo sapiens (Human)
Alternative Names
SNC19
Item Name
Suppression Of Tumorigenicity 14
Assay Length
3h
Method
Double-antibody Sandwich
Sample Type
tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Format
48T, 96T, 96T×5, 96T×10, 96T×100
Test Principle
Analyte-specific antibodies are pre-coated onto color-coded microparticles. Microparticles, standards, and samples are pipetted into wells and the immobilized antibodies bind the analytes of interest. After washing away any unbound substances, a biotinyla
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment
UniProt ID
AAH30532.1